Pharmacoeconomic feasibility of using the drug Hemangiol (propranolol, oral solution) in the treatment of proliferating infantile hemangioma requiring systemic therapy
Aim. The study aimed to evaluate the pharmacoeconomic feasibility of propranolol application in the dosage form of the oral solution in the treatment of proliferating infantile hemangioma requiring systemic therapy.Materials and methods. The study design was a retrospective analysis of the published...
Saved in:
Main Authors: | I. N. Dyakov, S. R. Varfolomeеva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2021-02-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/444 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Insights into Risk Factors for Infantile Hemangioma and Propranolol Treatment Outcomes
by: Ioana Roșca, et al.
Published: (2025-07-01) -
Results of Infantile Hemangioma Laser Therapy in Children with Persistent Residual Signs after Systemic Propranolol Therapy: Clinical Cases
by: Tatyana S. Belysheva, et al.
Published: (2021-11-01) -
Consumptive hypothyroidism complicating infantile hepatic hemangioma successfully treated with propranolol: a case report and literature review
by: Irene Bettini, et al.
Published: (2025-06-01) -
Hemangiomas infantiles
by: Andrés Tobón, et al.
Published: (2019-02-01) -
Infantile hepatic hemangioma and hepatic mesenchymal hamartoma in an infant associated with placental mesenchymal dysplasia: a case report
by: Shunsuke Fujii, et al.
Published: (2022-08-01)